Chemoinformaics analysis of 8-OXOTETRAHYDROPALMATINE
| Molecular Weight | 369.417 | nRot | 4 |
| Heavy Atom Molecular Weight | 346.233 | nRig | 22 |
| Exact Molecular Weight | 369.158 | nRing | 4 |
| Solubility: LogS | -3.838 | nHRing | 2 |
| Solubility: LogP | 2.366 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 55.5162 |
| nHD | 0 | BPOL | 32.5958 |
| QED | 0.829 |
| Synth | 2.823 |
| Natural Product Likeliness | 0.757 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.339 |
| Pgp-sub | 0.401 |
| HIA | 0.004 |
| CACO-2 | -4.762 |
| MDCK | 0.000023 |
| BBB | 0.736 |
| PPB | 0.924527 |
| VDSS | 0.763 |
| FU | 0.0625577 |
| CYP1A2-inh | 0.053 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.565 |
| CYP2c19-sub | 0.925 |
| CYP2c9-inh | 0.266 |
| CYP2c9-sub | 0.831 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.881 |
| CYP3a4-inh | 0.555 |
| CYP3a4-sub | 0.896 |
| CL | 5.082 |
| T12 | 0.363 |
| hERG | 0.021 |
| Ames | 0.218 |
| ROA | 0.296 |
| SkinSen | 0.084 |
| Carcinogencity | 0.038 |
| EI | 0.012 |
| Respiratory | 0.466 |
| NR-Aromatase | 0.622 |
| Antiviral | Yes |
| Prediction | 0.548667 |